Gradually depletion of BACE1 enzymes has been found in a study conducted by researchers from the Cleveland Clinic Lerner Research Institute to completely reverse the formation of amyloid plaques in the brains of model mice with Alzheimer’s disease improving the rodents’ cognitive functions without unwanted toxicity, raising hopes that drugs to target this enzyme will be able to be successful to treat the disease in humans, as published in the Journal of Experimental Medicine.
Read the Full Story at www.worldhealth.net
Alzheimer’s Disease Reversed
More from ResearchMore posts in Research »
- A possible blood test for early-stage Alzheimer’s disease | Medical Xpress
- Blood Biomarkers Plus Gene Status Predict Cognitive Decline : Neurology Today
- Early Detection of Alzheimer’s Prior to Onset of Symptoms Now Possible | Science Times
- We Need New Ideas for Fighting Alzheimer’s | Scientific American
- Immune view offers clues to early Alzheimer’s